scholarly journals Sleeve-Plus Procedures in Asia: Duodenojejunal Bypass and Proximal Jejunal Bypass

2021 ◽  
Author(s):  
Michelle Bernadette C. Lim-Loo ◽  
Chih-Kun Huang ◽  
Valerie Chan ◽  
Kathleen Chua
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Diabetes Remission ◽  
Intestinal Bypass ◽  
Duodenojejunal Bypass ◽  
Intestinal Hormones ◽  
Surgical Options ◽  
Treatment Of Obesity ◽  
Jejunal Bypass

Laparoscopic sleeve gastrectomy (SG) is the most commonly done bariatric procedure worldwide due to its technical ease. However, the physiologic effects of this procedure have limitations on glucose homeostasis for patients with type 2 Diabetes Mellitus (T2DM). This is due to the insufficient physiologic modulations from intestinal hormones. The Roux-en-Y gastric bypass (RYGB) has been proven to have better T2DM remission than SG due to more pronounced physiologic changes from foregut and hindgut hormone modulations. However, RYGB is technically challenging to perform and is accompanied by many potential postoperative complications, especially in terms of nutrition. The addition of an intestinal bypass to SG also induces said intestinal hormone changes to enhance diabetes remission. This chapter discusses the intestinal bypass that may be added to SG as surgical options for the treatment of obesity and T2DM with focus on duodenojejunal and proximal jejunal bypass.

Treatment of type 2 diabetes mellitus with the endoscopic duodenal-jejunal bypass liner (EndoBarrier®)

2014 ◽  
Vol 9 (S 01) ◽  
Author(s):  
K Laubner ◽  
L Potasso ◽  
N Perakakis ◽  
H Schwacha ◽  
J Seufert
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Jejunal Bypass

scholarly journals Advances in Acupuncture and its Associated Therapies for the Prevention and Treatment of Obesity Type 2 Diabetes Mellitus

2020 ◽  
Vol 4 (5) ◽  
Author(s):  
Kaiya Zhang ◽  
Yuanyuan Ren ◽  
Yanyan Zhou
Keyword(s):  
Diabetes Mellitus ◽  
Metabolic Disease ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Clinical Practice ◽  
Clinical Symptoms ◽  
Embedding Therapy ◽  
Prevention And Treatment ◽  
Treatment Of Obesity

Obesity type 2 diabetes mellitus is a common metabolic disease in clinical practice, and its prevalence is increasing rapidly with the aging of the population and changes in lifestyle. Acupuncture, as a distinctive therapy, has its unique advantages in the treatment of obesity type 2 diabetes and has an irreplaceable role in a variety of treatment methods. The author organized the literature on acupuncture and its related therapies to prevent and treat obesity type 2 diabetes in recent years and found that acupuncture and its associated therapies to prevent and treat obesity type 2 diabetes mainly include: simple acupuncture, electroacupuncture, acupoint catgut embedding therapy, auricular-plaster therapy and other treatments, all of which can safely and effectively improve clinical symptoms, acupuncture and its related therapies to treat obesity type 2 diabetes has a broad prospect, worthy of further clinical promotion.

Ketogenic diets as treatment of obesity and type 2 diabetes mellitus

2020 ◽  
Vol 21 (3) ◽  
pp. 381-397 ◽  
Author(s):  
Felipe F. Casanueva ◽  
Marco Castellana ◽  
Diego Bellido ◽  
Pierpaolo Trimboli ◽  
Ana I. Castro ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Ketogenic Diets ◽  
Treatment Of Obesity

scholarly journals Comparative long-term effectiveness and safety of primary bariatric surgeries in treating type 2 diabetes mellitus in adults: a protocol for systematic review and network meta-analysis of randomised controlled trials

BMJ Open ◽  
2019 ◽  
Vol 9 (4) ◽  
pp. e028430 ◽  
Author(s):  
Li Ding ◽  
Chuanjun Zhuo ◽  
Yuxin Fan ◽  
Yalan Zhang ◽  
Hui Li ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Diabetic Complications ◽  
Randomised Controlled Trials ◽  
Diabetes Remission ◽  
Controlled Trials ◽  
Randomised Controlled

IntroductionBariatric surgeries are effective in treating obesity related comorbidities, including type 2 diabetes mellitus. More robust evidence is needed to facilitate choice of procedure. In this systemic review, we aim to investigate the comparative long-term effectiveness in inducing remission of type 2 diabetes, halting diabetic complications, reducing mortality and the safety of conventional and emerging bariatric surgeries.Methods and analysisDatabases including Cochrane Central Register, EMBASE, MEDLINE and clinical trial registries will be searched for randomised controlled trials with at least 3 years of follow-up, including direct and/or indirect evidence regarding primary bariatric surgeries in overweight or obese adults with type 2 diabetes mellitus, from inception of each database to 2019, with no language or publication type limits imposed. Dual selection of studies, data extraction and risk of bias assessments will be performed. Primary outcomes include full diabetes remission, composite outcome of full or partial diabetes remission and adverse event profiles. Secondary outcomes include anthropometric measurements, cardiovascular risk factor burden, medication burden, diabetic complications and all-cause mortality. Given sufficient homogeneity, network meta-analyses will be performed in a random-effects model based on the Bayesian framework, while assessing for consistency between direct and indirect estimates. Heterogeneities of studies will be explored through meta-regression analysis, and robustness of findings will be checked by sensitivity analysis, and an alternative method under a frequentist framework. All statistical analysis and graphical presentations will be conducted by R software V.3.3.3 (The R Project for Statistical Computing). The overall quality of the evidence will be assessed using the Grading of Recommendations, Assessment, Development and Evaluation criteria for each outcome.Ethics and disseminationEthics approval is not required as individual patient data will not be included. This review will be subject for publication in a peer reviewed journal.PROSPERO registration numberCRD42018110775.

Sign in / Sign up

Export Citation Format

Share Document